🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objectives of this study are to assess: (1) whether the combina...
Status
Recruiting
Location
UCLA Medical Center
Start Date
2016-05
Trial ID
NCT02781883
Treatments Being Tested
The goal of this study is to assess the safety, tolerability, efficacy, pha...
Status
Recruiting
Location
Centre Hospitalier Universitaire Grenoble Alpes
Start Date
2024-01-05
Trial ID
NCT06191263
Treatments Being Tested
This study intends to use a randomized controlled design to compare the MRD...
Status
Enrolling By Invitation
Location
Department of Hematology, Guangdong Second Provincial General Hospital
Start Date
2026-04-01
Trial ID
NCT07537257
Treatments Being Tested
HEM-iSMART is a master protocol which investigates multiple investigational...
Status
Recruiting
Location
St. Anna Kinderspital
Start Date
2025-10-01
Trial ID
NCT05751044
Treatments Being Tested
This study is a non-profit, prospective, single-center, open-label, control...
Status
Enrolling By Invitation
Location
Department of Hematology, The First Affiliated Hospital of Anhui Medical University, 218 Jixi Road
Start Date
2025-02-01
Trial ID
NCT06697327
Treatments Being Tested
This is a multicenter, open-label, Phase 1/2a dose escalation and expansion...
Status
Suspended
Location
Moffitt Cancer Center
Start Date
2020-07-06
Trial ID
NCT04278768
Treatments Being Tested
The purpose of this study is to test the safety of Venetoclax in combinatio...
Status
Completed
Location
Memorial Sloan Kettering Basking Ridge
Start Date
2017-09-20
Trial ID
NCT03295240
Treatments Being Tested
Venetoclax plus azacitidine are effective in treating newly diagnosed AML i...
Status
Completed
Location
Andres Gomez
Start Date
2021-07-26
Trial ID
NCT05048615
Treatments Being Tested